News Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Staff June 25, 2022 Iframe sync Post navigation Previous: Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical UpdateNext: Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 NASH Data and Multiple Oral Abstracts at EASL’s International Liver Congress™ More Stories Antimicrobial Brain News Pregnancy Kirkman(R) Unveils Revolutionary L Reuteri: a Brain-Protective Probiotic with Immune Benefits Staff February 2, 2026 Clinical Trial Diagnostics EHR Genetic Testing Healthcare Hospitals News Pharmaceutical Telemedicine IoT in Healthcare Market to Reach US$594.5 Bn by 2035 at 23.85% CAGR | Vantage Market Research Staff February 2, 2026 Epidemics Healthcare Hospitals Medicaid Medicare News Nursing Pharmaceutical NHI Announces $105.5 Million SHOP Investment Staff February 2, 2026
